| 1 |
33411110 | Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant. | 2022 Feb |
1 |
| 2 |
33335233 | Molecular determinant of substrate binding and specificity of cytochrome P450 2J2. | 2020 Dec 17 |
1 |
| 3 |
29759885 | Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes. | 2018 Jun |
4 |
| 4 |
28237650 | Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy. | 2017 Jul 1 |
1 |
| 5 |
28698302 | Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds. | 2017 Sep |
2 |
| 6 |
26048912 | Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner. | 2015 Aug |
8 |
| 7 |
24021950 | Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes. | 2013 Dec |
1 |
| 8 |
22328583 | Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. | 2012 May |
1 |
| 9 |
19923256 | Identification of novel substrates for human cytochrome P450 2J2. | 2010 Feb |
1 |